PH12016500950A1 - Infant nutrition for improvement in insulin sensitivity later in life - Google Patents

Infant nutrition for improvement in insulin sensitivity later in life

Info

Publication number
PH12016500950A1
PH12016500950A1 PH12016500950A PH12016500950A PH12016500950A1 PH 12016500950 A1 PH12016500950 A1 PH 12016500950A1 PH 12016500950 A PH12016500950 A PH 12016500950A PH 12016500950 A PH12016500950 A PH 12016500950A PH 12016500950 A1 PH12016500950 A1 PH 12016500950A1
Authority
PH
Philippines
Prior art keywords
life
improvement
insulin sensitivity
infant nutrition
later
Prior art date
Application number
PH12016500950A
Inventor
Blancher Florence
Mace Catherine
Shahkhalili Dulloo Yassaman
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PH12016500950A1 publication Critical patent/PH12016500950A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1524—Inert gases, noble gases, oxygen, aerosol gases; Processes for foaming
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

The present invention relates to a nutritional composition for use in treatment, prevention and/or reducing the risk of a metabolic syndrome disorder appearing later in life, wherein the nutritional composition comprises casein.
PH12016500950A 2013-11-29 2016-05-23 Infant nutrition for improvement in insulin sensitivity later in life PH12016500950A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13195014 2013-11-29
PCT/EP2014/075831 WO2015078974A1 (en) 2013-11-29 2014-11-27 Infant nutrition for improvement in insulin sensitivity later in life

Publications (1)

Publication Number Publication Date
PH12016500950A1 true PH12016500950A1 (en) 2016-06-27

Family

ID=49679400

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016500950A PH12016500950A1 (en) 2013-11-29 2016-05-23 Infant nutrition for improvement in insulin sensitivity later in life

Country Status (8)

Country Link
US (1) US10821150B2 (en)
EP (1) EP3082472A1 (en)
CN (1) CN105578904A (en)
AU (1) AU2014356485A1 (en)
MX (1) MX2016006882A (en)
PH (1) PH12016500950A1 (en)
RU (1) RU2694827C1 (en)
WO (1) WO2015078974A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3854227A1 (en) * 2016-04-11 2021-07-28 Société des Produits Nestlé S.A. Infant nutrition delivering metabolic benefits
MX2021005668A (en) * 2018-11-30 2021-06-15 Nestle Sa Infant nutritional composition for use in the enhancement of pancreatic maturation and insulin biosynthesis.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083164A2 (en) 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
DK2554056T3 (en) * 2008-09-02 2020-02-24 Nutricia Nv Nutrient compositions with large diameter lipid spheres and a coating comprising phospholipids
MY161505A (en) 2009-04-01 2017-04-14 Nestec Sa Reduction of risk of obesity
AU2010230283B2 (en) * 2009-04-03 2015-02-05 Société des Produits Nestlé S.A. Improvement in promotion of healthy catch-up growth
WO2010119088A2 (en) 2009-04-15 2010-10-21 Bodo Melnik Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity
EP2583562A1 (en) 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
CN104302192A (en) 2011-12-27 2015-01-21 雅培制药有限公司 Reduced calorie infant formulas containing specific whey to casein ratios

Also Published As

Publication number Publication date
MX2016006882A (en) 2016-08-17
RU2694827C1 (en) 2019-07-17
US10821150B2 (en) 2020-11-03
AU2014356485A1 (en) 2016-03-03
CN105578904A (en) 2016-05-11
US20160296585A1 (en) 2016-10-13
EP3082472A1 (en) 2016-10-26
WO2015078974A1 (en) 2015-06-04

Similar Documents

Publication Publication Date Title
NZ750707A (en) Cot modulators and methods of use thereof
MX2015008114A (en) Exendin-4 Derivatives.
MX2014015423A (en) Exendin-4 peptide analogues.
PH12016500774A1 (en) Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
PH12017500052A1 (en) Myo-inositol and probiotics and uses
PH12017500017A1 (en) A combination of vitamin d and zinc and its use
PH12014502071A1 (en) Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance
MX2015017638A (en) Tannin-containing polyols, their production and use.
WO2014147503A3 (en) Anti-bag3 antibodies for therapeutic use
MX2017002796A (en) Tasimelteon for treating smith-magenis syndrome.
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
PH12017501290A1 (en) Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide
PH12016501867A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12016501868A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12016500950A1 (en) Infant nutrition for improvement in insulin sensitivity later in life
PH12016501947A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12017500084A1 (en) Vitamin b2 and its use
PH12016501817A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
MX2015009161A (en) Polyols, production and use thereof.
MX345908B (en) Edible energy composition.
PH12016501919A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12016501918B1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12016501920A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
MX2016015137A (en) Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them.
MX2015017136A (en) Composition for the oral administration of magnesium, in association with a composition for treating type 2 diabetes or the complications thereof.